发明名称 Ester pro-drugs of [3-(1-(1H-imidazol-4-YL)ethyl)-2-methylphenyl] methanol for treating retinal diseases
摘要 The present invention relates to method of treating retinal diseases in a subject in need of such treatment, which comprises administering a therapeutically effective amount of a composition comprising a ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl]methanol, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
申请公布号 US8853251(B2) 申请公布日期 2014.10.07
申请号 US201314071090 申请日期 2013.11.04
申请人 Allergan, Inc. 发明人 Dibas Mohammed I.;Gil Daniel W.;Chow Ken;Wang Liming;Garst Michael E.;Donello John E.
分类号 A61K31/415;A61K31/4174;A61K31/4164;C07D233/64 主分类号 A61K31/415
代理机构 代理人 Ene Doina G.
主权项 1. A method of treating retinal diseases, selected from dry macular degeneration and geographic atrophy, in a subject in need of such treatment, which comprises administering a pharmaceutical composition comprising a therapeutically effective amount of a compound having Formula I, its individual enantiomers, its individual tautomers or a pharmaceutically acceptable salt thereof, thereof, wherein R1 is H or C1-3 alkyl; R2 is H or C1-3 alkyl; R3 is H, C1-10 alkyl, heterocycle or aryl; and R is C1-10 alkyl, heterocycle or aryl.
地址 Irvine CA US